Published in Cancer Weekly, January 9th, 2007
Tepper was one of the founding executives of Millennium in 1994 and has steered the company through its expansion from a drug discovery company to a fully-integrated biopharmaceutical company with nine novel molecules in the clinic and a market-leading product, Velcadae (bortezomib) for Injection, for relapsed multiple myeloma and mantle cell lymphoma.
"Bob was one of a small group of people who had a vision for forming a new company that could make a difference in the way medicine is discovered to change the lives...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.